As MAP3K3 is critically involved in nasopharyngeal carcinoma development, exploiting the suppressive role of miR‐194 on nasopharyngeal carcinoma might be an effective rationale for diagnosis and treatment of nasopharyngeal carcinoma. The gene discussed is MAP3K3; the disease is nasopharyngeal carcinoma.